Prakt. lékáren. 2014; 10(6): 221-225

Basiscreme DAC − a novel cream basis for extemporaneous preparation, part 2

Jan Hašek
Lékárna U Matky Boží, Doksy

The second part of the article on Basiscreme DAC (Cremor basalis DAC) cream basis deals with the options of use in extemporaneous formulation

in terms of the requirements of Czech prescription. Major attention is paid to topical corticosteroids. Also presented is a comparison with the

other hydrocream bases, the properties of which often restrict a more versatile use. Emphasis is also placed on formulations in which there

is improper mixing of proprietary medicinal products and where more rational alternatives using active pharmaceutical ingredients are available.

anal fissures.

Keywords: extemporaneous preparation, hydrophilic creams, Basiscreme DAC, topical corticosteroids, stability of medicinal products,

Published: December 16, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hašek J. Basiscreme DAC − a novel cream basis for extemporaneous preparation, part 2. Praktické lékárenství. 2014;10(6):221-225.
Download citation

References

  1. Garbe C, Reimann H. Dermatologische Rezepturen. 2 vyd. Gregor Thieme Verlag, 2005: 320. Go to original source...
  2. Sklenář Z, et al. Magistraliter receptura v dermatologii. 1. vyd. Praha: Galén, 2009.
  3. Hašek J. Aniontový krém v magistraliter receptuře. Prakt. lékáren. 2013; 9(1): 18-22.
  4. Deutscher Arzneimittel-Codex (DAC) 2007/Neues Rezeptur-Formularium (NRF). Band I-III. Pharmazeutischen Laboratorium des NRF. Eschborn: Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2007.
  5. Rowe RC, Sheskey PJ, Owen SC. Pharmaceutical excipients 2004 (Singleuser version). [CD-ROM]. Washington, DC: Pharmaceutical Press and American Pharmacists Association, 2004.
  6. Luger T, Loske KD, Elsner P, et al. Topische Dermatotherapie mit Glukokortikoiden - Therapeutischer Index. J Dtsch Dermatol Ges 2004; 2: 629-634. Go to original source... Go to PubMed...
  7. Teng XW, Cutler DC, Davies NM. Degradation kinetics of mometasone furoate in aqueous systems. Int J Pharm. 2003; 259(1-2): 129-141. Go to original source... Go to PubMed...
  8. Sarfaraz K. Niazi, Handbook of Pharmaceutical Manufacturing Formulations, Semisolid Products (svazek 4)), Taylor & Francis, 2004: 263.
  9. Sklenář Z, Ščigel V. Magistraliter receptura ve stomatologii. Praha: 2013. Havlíček Brain Team.
  10. Rezepturhinweise NRF: Mometasonfuroat - Neues Rezeptur-Formularium. Pharmazeutische Zeitung, Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2013. Dostupné na http://dacnrf.pharmazeutische-zeitung.de/fileadmin/nrf/pdf/1-Mometasonfuroat.pdf Datum náhledu 2.10.2014.
  11. Wurm G. Galenische Übungen. 18. vyd. Eschborn: Govi- Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2011: 504.
  12. http://dacnrf.pharmazeutische-zeitung.de/index.php?id=rezepturenfinderdetail&uid=1316 Datum náhledu 2.10.2014.
  13. Pauke C, Dreeke-Ehrlich M. Receptur für die Kitteltasche, 3. vyd. Stuttgart Deutscher Apotheker Verlag Stuttgart 2010: 451.
  14. Ezri T, Susmallian S. Topical nifedipine vs. topical glyceryl trinitrate for treatment of chronic anal fissure. Dis Colon Rectum. 2003; 46(6): 805-808. Go to original source... Go to PubMed...
  15. Perrotti P, Grumetto L, Barbato F, Antropoli C. Serum levels and possible haemodynamic effects following anorectal application of an ointment containing nifedipine and lignocaine: a study in healthy volunteers. Clin Drug Investig. 2006; 26(8): 459-467. Go to original source... Go to PubMed...
  16. Rezepturhinweise NRF. Mometasonfuroat - Neues Rezeptur-Formularium. Pharmazeutische Zeitung, Govi-Verlag und Stuttgart: Deutscher Apotheker-Verlag, 2014. Dostupné na http://dacnrf.pharmazeutische-zeitung.de/fileadmin/nrf/pdf/1-Nifedipin.pdf. Datum náhledu 2.10.2014.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.